P16INK4a Negative Oropharyngeal Squamous Cell Carcinoma
Also known as: Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB14547 | Chloride ion | 2 | Recruiting | 1 |
| DB00515 | Cisplatin | 2 | Recruiting | 1 |
| DB12257 | Platinum | 2 | Recruiting | 1 |
| DB11595 | Atezolizumab | 2 / 3 | Recruiting | 1 |
| DB11595 | Atezolizumab | 2 / 3 | Suspended | 1 |
| DB00002 | Cetuximab | 2 / 3 | Recruiting | 1 |
| DB00002 | Cetuximab | 2 / 3 | Suspended | 1 |
| DB14547 | Chloride ion | 2 / 3 | Recruiting | 1 |
| DB14547 | Chloride ion | 2 / 3 | Suspended | 1 |
| DB00515 | Cisplatin | 2 / 3 | Recruiting | 1 |
| DB00515 | Cisplatin | 2 / 3 | Suspended | 1 |
| DB01248 | Docetaxel | 2 / 3 | Recruiting | 1 |
| DB01248 | Docetaxel | 2 / 3 | Suspended | 1 |
| DB12257 | Platinum | 2 / 3 | Recruiting | 1 |
| DB12257 | Platinum | 2 / 3 | Suspended | 1 |